Table of Content

1. Service Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customers
5. Impact of COVID-19 on Japan Rare Disease Diagnostics Market
6. Japan Rare Disease Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.3. By Indication (Gastroenterology Disease, Endocrine & Metabolism Disorders Disease, Cardiovascular Disorders, Hematology & Oncology Disease, Others)
6.3.1. By Trait Type (Inherited, Acquired)
6.3.2. By Test Type (Genetic Tests, General Lab Tests, Diagnostic Imaging, Others)
6.3.3. By Technique (Next Generation Sequencing, Whole Genome Sequencing, Whole Exosome Sequencing, Microarray, Others)
6.3.4. By Sample Type (DNA Sample, Blood Sample, Saliva Sample, Others)
6.3.5. By End User (Hospitals & Clinics, Academic & Research Institutions, Others)
6.3.6. By Region
6.3.7. By Company (2023)
6.4. Market Map
7. Japan Inherited Rare Disease Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Test Type
7.2.3. By Technique
7.2.4. By Sample Type
7.2.5. By End User
8. Japan Acquired Rare Disease Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Indication
8.2.2. By Test Type
8.2.3. By Technique
8.2.4. By Sample Type
8.2.5. By End User
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
10.1. Merger & Acquisition
10.2. Product Development
10.3. Recent Developments
11. Porters Five Forces Analysis
11.1. Competition in the Industry
11.2. Potential of New Entrants
11.3. Power of Suppliers
11.4. Power of Customers
11.5. Threat of Substitute Products
12. Japan Rare Disease Diagnostics Market: SWOT Analysis
13. Policy & Regulatory Landscape
14. Japan Economic Profile
15. Competitive Landscape
15.1. Takeda Pharmaceutical Co.
15.2. Fujirebio Inc.
15.3. Medical & Biological Laboratories Co., Ltd. (MBL)
15.4. Tosoh Corporation
15.5. Sysmex Corporation
15.6. Eiken Chemical Co., Ltd.
15.7. TaKaRa Bio Inc
15.8. CSL Behring Products
15.9. JCR Pharmaceuticals Co., Ltd.
15.10. Sekisui Medical Co., Ltd.
16. Strategic Recommendations
17. About Us & Disclaimer